D.A.A.6 Xplode from Beverly Nutrition is a compound with high concentrations of D – aspartic acid, an amino acid capable of increasing testosterone levels naturally and safely. D.A.A.6 Xplode has been proved to be very safe and effective to increase testosterone levels naturally by up to 50 % noting its powerful effects in just a few days.
D.A.A.6 Xplode plays an important role in the release of luteinizing hormone (LH), growth hormone (GH) and nervous system function , up to 50% by increasing testosterone levels in the body in a natural , fast and safe way.
D.A.A.6 Xplode causes a great impact, more than 200% in increasing in strength, power, energy and muscle growth without adding even a single gram of fat, creating new muscle cells free of fatty tissue, in other words, dry large rocky muscle.
D.A.A.6 Xplode also contains Tongkat Ali extract which produces a significant increase in muscle especially in men, this compound will produce an additional 5% increase in body mass acting at the same time as a potent fat burner. Tongkat Ali is more powerful than herb tribulus terrestris which takes years to mature. The full development is achieved in 25 years, hence its powerful benefits.
D.A.A.6 Xplode Benefits:
- It increases strength
- It increases muscle mass
- It increases power and energy
- Feeling of well-being
- It increases libido improving sexual life
- It acts as a powerful fat burner
Bottle with 120 capsules
DATASHEET: DAA6 XPLODE 120 CAP
LEGAL NOTE: Products reviewed here are food supplements or as established by European Directive 2002/46/EC on food supplements and all can be legally sold in all countries of the European Community, under Articles 28, 29 and 30 of the treaty the European Community and by Articles 1 to 4 of the European Parliament Decision 3052/95/EC number. Dietary supplements are not trying to replace a balanced and varied diet, are presented only in order to supplement the intake of nutrients of a normal diet. Neither treat, prevent, diagnose or cure any disease, acts attributable to drugs, as defined by European Directive 2004/27/EC of 31 March, the Council and European Parliament on medicinal products.